News

Barbara Milczarek for The World of Pharmaceutical Industry Magazine!

In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.


Troubles of a deli meat producer – a dispute over exclusive rights

The gourmets of deli meats are undoubtedly well-familiar with the word-figurative trademark which represents the Czytaj dalej

Join us at INTA 2024!

Each year, INTA brings together top intellectual property and business experts from around the world, Czytaj dalej